The Campbell's Company (CPB) Stock Price & Analysis
The Campbell's Company (CPB) closed at USD 21.26 on Thursday, October 22, 2026, up 8.69% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 19.56; the Oct 22, 2026 session ranged USD 19.81–21.3 on volume of 9,842,990 shares. Market capitalization is $6.34B, with a 52-week range of USD 18.6–32.04 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:49 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CPB.md
Key facts (CPB)
- Last four reported quarters (through Aug 2, 2026): revenue $9.74B, net income $403M (4.1% margin), free cash flow $678M (SEC filings).
- Valuation: P/E 15.7x (avg 19.4x at the last 3 fiscal year-ends), EV/EBITDA 10.3x, net debt $6.74B.
- Earnings quality: non-operating income -$171M vs operating income $852M over the last four quarters; P/E excluding non-operating income ≈11.9x (estimate: non-operating income taxed at the company's 23.4% effective rate).
- 3 of 80 tracked superinvestors hold CPB (13F, Q2 2026): 1 new, 0 added, 2 reduced, 0 unchanged.
- Analysts: Hold (mean 3.45 on a 1–5 scale) (20 analysts), mean target USD 20.79 (range 16–41.5).
- Total return with dividends: 1Y -27.1% vs S&P 500 +14.9%; 5Y -36.1% vs S&P 500 +80.3%.
- Next earnings: 2026-09-03, EPS estimate USD 0.41, revenue estimate $2.56B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CPB)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $8.56B | $9.36B | $9.64B | $10.3B | $9.74B | $9.74B |
| Gross profit | $2.63B | $2.92B | $2.97B | $3.12B | $2.74B | — |
| Operating income | $1.16B | $1.31B | $1.00B | $1.12B | $852M | $852M |
| Net income | $757M | $858M | $567M | $602M | $403M | $403M |
| EPS (diluted) | $2.51 | $2.85 | $1.89 | $2.01 | $1.31 | — |
| Free cash flow | $939M | $773M | $668M | $705M | $678M | $678M |
| Gross margin | 30.7% | 31.2% | 30.8% | 30.4% | 28.1% | — |
| Operating margin | 13.6% | 14.0% | 10.4% | 11.0% | 8.7% | 8.7% |
| Net margin | 8.8% | 9.2% | 5.9% | 5.9% | 4.1% | 4.1% |
| Revenue growth | +1.0% | +9.3% | +3.0% | +6.4% | -5.0% | — |
| Cash + short-term investments | $109M | $189M | $108M | $132M | $394M | — |
| Total debt | $4.81B | $4.69B | $7.18B | $6.86B | $7.14B | — |
Fiscal years end Aug. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Aug 2, 2026) (CPB)
P/E 15.7x · P/E ex non-operating (est.) ≈11.9x · P/S 0.7x · EV/EBITDA 10.3x · EV/Sales 1.3x · P/FCF 9.4x · P/B 1.6x · FCF yield 10.69% · Earnings yield 6.36% · Dividend yield (paid, TTM) 7.41% · Buyback yield (TTM) 0.41% · Net debt $6.74B · EV $13.1B
P/E at fiscal year-ends: Aug 2026 17.6x, Aug 2025 15.9x, Jul 2024 24.8x.
Superinvestors (SEC 13F-HR, Q2 2026) (CPB)
3 of 80 tracked investors hold CPB. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Hillman Capital | Hillman Capital Management | 2.60% | $3.6M | Reduced -3.1% |
| Bruce Berkowitz | Fairholme Capital | 0.17% | $2.6M | New position |
| Jensen Investment Management | 0.01% | $484K | Reduced -30.8% |
Analysts (CPB)
Consensus Hold (mean 3.45 on a 1–5 scale), 20 analysts; mean target USD 20.79 (low 16, high 41.5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-14 | Evercore ISI Group | Target lowered | In-Line | $22 → $21 |
| 2026-09-08 | DA Davidson | Maintained | Neutral | $20 |
| 2026-09-04 | RBC Capital | Target lowered | Sector Perform | $21 → $19 |
| 2026-09-04 | UBS | Target raised | Sell | $18 → $19 |
| 2026-09-04 | Barclays | Target lowered | Underweight | $19 → $18 |
| 2026-09-04 | Jefferies | Target lowered | Hold | $22 → $20 |
| 2026-08-31 | RBC Capital | Reiterated | Sector Perform | $21 |
| 2026-08-31 | Evercore ISI Group | Target lowered | In-Line | $23 → $22 |
| 2026-08-20 | UBS | Target raised | Sell | $17 → $18 |
| 2026-08-19 | TD Cowen | Target raised | Hold | $20 → $22 |
| 2026-08-18 | JP Morgan | Target raised | Neutral | $20 → $22 |
| 2026-07-22 | Stifel | Target raised | Hold | $20 → $22 |
Total return (dividends reinvested) (CPB)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -27.1% | -36.1% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -27.2% | -8.6% |
| Volatility (annualized) | 33.4% | 24.4% |
| Max drawdown | -36.5% (Nov 2025→Oct 2026) | -60.5% (Jan 2023→Sep 2026) |
CPB revenue by business segment (quarter ended Aug 2, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Meals & Beverages | $1.19B | 55.5% | -4.0% |
| Snacks | $950.0M | 44.5% | -12.4% |
| Total revenue | $2.14B | 100% | — |
CPB revenue by product line (quarter ended Aug 2, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Snacks | $1.03B | 48.4% | -12.1% |
| Other Simple Meals | $520.0M | 24.3% | +4.0% |
| Soup | $419.0M | 19.6% | -7.7% |
| Beverages | $163.0M | 7.6% | -14.2% |
| Total revenue | $2.14B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
CPB suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Walmart (WMT) | “Our largest customer, Walmart Inc. and its affiliates, accounted for approximately 22% of our consolidated net sales in 2026, 21% in 2025, and 22% in 2024.” |
Quoted from the company's 10-K filed Sep 24, 2026.
CPB customer concentration
In the period ended Aug 2, 2026, a single direct customer accounted for 22% of revenue, per the company's 10-K filed Sep 24, 2026. The company does not name it.
CPB company outlook (results filed Sep 3, 2026)
- “Fiscal 2027 Guidance: The company's outlook reflects an external environment which we expect will remain volatile, another year of elevated inflation, and several longer-term benefits that are expected to build through the year to increasingly support our margins.”
- “Note: A non-GAAP reconciliation is not provided for fiscal 2027 guidance as the company is unable to reasonably estimate the full-year financial impact of items such as actuarial gains or losses on pension and postretirement plans because these impacts are dependent on future changes in market conditions.”
Quoted word-for-word from the SEC 8-K results press release.
CPB analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Oct 2026) | $0.41 | $0.61 | -32.0% | $2.56B | 16 |
| Next quarter (ends Jan 2027) | $0.42 | $0.47 | -11.3% | $2.50B | 16 |
| Current fiscal year (ends Jul 2027) | $1.70 | $1.95 | -13.1% | $9.50B | 20 |
| Next fiscal year (ends Jul 2028) | $1.84 | $2.11 | -13.0% | $9.47B | 19 |
CPB options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 32.9% | ±4.0% |
| Nov 6, 2026 | 14 | 34.4% | ±5.7% |
| Nov 13, 2026 | 21 | 35.2% | ±7.0% |
| Nov 20, 2026 | 28 | 34.4% | ±7.8% |
| Nov 27, 2026 | 35 | 33.9% | ±8.5% |
| Dec 18, 2026 | 56 | 37.5% | ±11.8% |
| Jan 15, 2027 | 84 | 34.7% | ±13.6% |
| Feb 19, 2027 | 119 | 35.5% | ±16.0% |
30-day implied volatility 33% vs 38.4% realized over the last 30 trading days. Put/call ratio (volume) 0.29. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:49 UTC)
| Price | USD 21.26 |
|---|---|
| Change | ▲ 8.69% (up) |
| Previous Close | USD 19.56 |
| Open | USD 19.84 |
| Day Range | USD 19.81 – 21.3 |
| 52-Week Range | USD 18.6 – 32.04 |
| Volume | 9,842,990 shares |
| Market Cap | $6.34B |
| Exchange | NMS |
Technical Analysis (CPB)
Nexqual's technical model rates CPB "NEUTRAL" based on 4 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:49 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 61.3 (neutral) |
| vs SMA50 | Above (USD 21.17) |
| MACD | -0.24 (negative) |
Analyst Ratings (CPB)
Wall Street analysts rate CPB "Hold" based on 20 analysts, with a mean price target of USD 20.79 (range USD 16–41.5), per Nexqual as of October 23, 2026 at 09:49 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 20 |
| Mean Target | USD 20.79 |
| High Target | USD 41.5 |
| Low Target | USD 16 |
| Buy / Hold / Sell | 1 / 13 / 6 |
Earnings (CPB)
| Next Earnings Date | 2026-09-03 |
|---|---|
| EPS Estimate | USD 0.41 |
| Revenue Estimate | $2.56B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-07-31 | USD 0.39 vs est 0.39 ▲ beat |
| 2026-04-30 | USD 0.5 vs est 0.48 ▲ beat |
| 2026-01-31 | USD 0.51 vs est 0.57 ▼ miss |
| 2025-10-31 | USD 0.77 vs est 0.73 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:49 UTC.
Financials & Fundamentals (CPB)
| Total Revenue | $9.74B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -7.90% |
| Gross Margin | +28.54% |
| Operating Margin | +10.20% |
| Profit Margin | +4.14% |
| ROE | +10.05% |
| Debt / Equity | 1.79 |
| Current Ratio | 0.82 |
| Total Cash | $394.00M |
| Total Debt | $7.45B |
| Free Cash Flow (last four quarters to Aug 2026, SEC 10-Q / 10-K) | $678.00M (7.0% of revenue) |
Source: Nexqual, October 23, 2026 at 09:49 UTC.
Financial Health Score (CPB)
Nexqual rates The Campbell's Company's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:49 UTC.
| Growth | Weak — Revenue -5% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 29%, operating 10% (last 12 months) |
| Balance Sheet | Critical — $394M cash and investments vs $7.14B debt (Aug 2026, SEC) |
| Cash Flow | Solid — FCF $678M (last 4 quarters to Aug 2026, SEC), 7% margin |
| Efficiency | Mixed — ROE 10%, ROA 4.9% |
Ownership (CPB)
| Insider Ownership | +40.16% |
|---|---|
| Institutional Ownership | +62.93% |
| Shares Outstanding | 298.23M |
| Float | 192.41M |
| Short % of Float | +23.16% |
Source: Nexqual, October 23, 2026 at 09:49 UTC.
Leadership (CPB)
The Campbell's Company is led by Mick J. Beekhuizen, CEO, President & Director, per Nexqual as of October 23, 2026 at 09:49 UTC.
| CEO, President & Director | Mick J. Beekhuizen |
|---|---|
| Executive VP & Chief Financial Officer | Todd E. Cunfer |
| Executive VP & President of Snacks | Mohit Anand |
Major Backers & Investors (CPB)
Notable institutional backers of The Campbell's Company include Two Sigma Investments, LP, Morgan Stanley, UBS Group AG, according to Nexqual as of October 23, 2026 at 09:49 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Two Sigma Investments, LP | 2.7% |
| Morgan Stanley | 2.37% |
| UBS Group AG | 2.17% |
| Brandes Investment Partners L.P. | 2.12% |
| Goldman Sachs | 1.66% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Targeted Value Portfolio | 0.6% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 9.79% |
| Vanguard Group | 7.26% |
| Dimensional Fund Advisors | 2.87% |
| State Street | 2.61% |
Source: Nexqual, October 23, 2026 at 09:49 UTC.
From The Campbell's Company's Latest SEC 10-K Filing (filed 2026-09-24)
Key Strengths & Strategy (as disclosed to the SEC)
- Major capital projects based on planned spend in 2027 include sustaining our infrastructure, including wastewater initiatives, and network optimization projects.
Legal & Regulatory Risks (Item 1A, quoted)
- We may be adversely impacted by legal and regulatory proceedings or claims.
- We may suffer losses if changes to regulations require us to change the ingredients we use or how we process, package, transport, store, distribute, advertise, or label our products.
- We have in the past and we may, in the future, need to recall some of our products if they become adulterated or if they are mislabeled, and we may also be liable if the consumption of any of our products causes sickness or injury to consumers.
- Climate change, or legal, regulatory or market measures to address climate change, may negatively affect our business and operations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INGR | Ingredion Incorporated | USD 97.18 | ▲ 1.57% |
| PPC | Pilgrim's Pride Corporation | USD 28.09 | ▲ 1.23% |
| CAG | ConAgra Brands, Inc. | USD 15.07 | ▲ 7.34% |
| SFD | Smithfield Foods, Inc. | USD 18.81 | ▲ 2.79% |
| LW | Lamb Weston Holdings, Inc. | USD 55.18 | ▲ 3.9% |
| DAR | Darling Ingredients Inc. | USD 55.64 | ▼ 5.84% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:49 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt